Glioma

Findings from University of Western Ontario provide new insights into glioma

Published in Cancer Weekly, January 26th, 2010

In this recently published article, scientists in London, Canada conducted a study "To report the long-term follow-up of a cohort of adult patients with supratentorial low-grade glioma treated at a single institution. A cohort of 145 adult patients treated at the London Regional Cancer Program between 1979 and 1995 was reviewed."

"With a median follow-up of 105 months, the median progression-free survival was 61 months (95 % confidence interval, 53-77), and the median overall survival was 118 months (95 % confidence interval, 93-129). The 10- and 20-year progression-free and overall survival rate was 18 % and 0 % and 48 % and 22 %, respectively. Cox regression analysis...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2010-01-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry